Abstract:The aim of this study was to analyze clinical/genetic data regarding a possible genotype–phenotype correlation in individuals with disease‐causing variants in COL4A3/COL4A4 associated with Alport syndrome. An association of heterozygous non‐truncating variants with a more severe phenotype in comparison to truncating variants could be shown indicating a potential dominant‐negative effect. Alport syndrome (AS) shows a broad phenotypic spectrum ranging from isolated microscopic hematuria (MH) to end‐stage kidney disease (ESKD). Monoallelic disease‐causing variants in COL4A3/COL4A4 have been associated with autosomal dominant AS (ADAS) and biallelic variants with autosomal recessive AS (ARAS). The aim of this study was to analyze clinical and genetic data regarding a possible genotype–phenotype correlation in individuals with disease‐causing variants in COL4A3/COL4A4. Eighty‐nine individuals carrying at least one COL4A3/COL4A4 variant classified as (likely) pathogenic according to the American College of Medical Genetics guidelines and current amendments were recruited. Clinical data concerning the prevalence and age of first reported manifestation of MH, proteinuria, ESKD, and extrarenal manifestations were collected. Individuals with monoallelic non‐truncating variants reported a significantly higher prevalence and earlier diagnosis of MH and proteinuria than individuals with monoallelic truncating variants. Individuals with biallelic variants were more severely affected than those with monoallelic variants. Those with biallelic truncating variants were more severely affected than those with compound heterozygous non‐truncating/truncating variants or individuals with biallelic non‐truncating variants. In this study an association of heterozygous non‐truncating COL4A3/COL4A4 variants with a more severe phenotype in comparison to truncating variants could be shown indicating a potential dominant‐negative effect as an explanation for this observation. The results for individuals with ARAS support the, still scarce, data in the literature.

Heterozygous COL17A1 variants are a frequent cause of amelogenesis imperfecta

Epithelial recurrent erosion dystrophy (ERED) from the splice site altering COL17A1 variant c.3156C>T in families of Finnish‐Swedish ancestry

Mutant B3GALT6 in a Multiplex Family: A Dominant Variant Co-Segregated with Moderate Malformations

A Novel Compound Heterozygous CYP17A1 Variant Causes 17α-Hydroxylase/17, 20-Lyase Deficiency.

Independent COL17A1 Variants in Cats with Junctional Epidermolysis Bullosa

COL17A1 germline variant p.Ser1029Ala and mucosal malignant melanoma: An autopsy study

A novel homozygous point mutation in the COL17A1 gene in a Chinese family with generalized atrophic benign epidermolysis bullosa.

Identification of a Novel COL17A1 Compound Heterozygous Mutation in a Chinese Girl with Non-Herlitz Junctional Epidermolysis Bullosa

Exclusion of the human collagen type XVII (COL17A1) gene as the cause of Thiel-Behnke corneal dystrophy (CDB2) on chromosome 10q23-q25

Mutations in collagen genes: causes of rare and some common diseases in humans

Digenic inheritance accounts for phenotypic variability in amelogenesis imperfecta

COL12A1 Gene Variant and a Review of the Literature: A Case Report of Ullrich Congenital Muscular Dystrophy

Identification of a missense mutation of COL3A1 in a Chinese family with atypical Ehlers-Danlos syndrome using targeted next-generation sequencing.

Novel COL5A1 variants and associated disease phenotypes in dogs with classical Ehlers-Danlos syndrome

Identification of two novel COL3A1 variants in patients with vascular Ehlers-Danlos syndrome

Novel Mutations in COL6A3 That Associated With Peters’ Anomaly Caused Abnormal Intracellular Protein Retention and Decreased Cellular Resistance to Oxidative Stress

Generation of two iPSC lines from vascular Ehlers-Danlos Syndrome (vEDS) patients carrying a missense mutation in COL3A1 gene

Is there a dominant‐negative effect in individuals with heterozygous disease‐causing variants in COL4A3/COL4A4?

A mutation in CCDC91, Homo sapiens coiled-coil domain containing 91 protein, cause autosomal-dominant acrokeratoelastoidosis

Heterozygous THBS2 pathogenic variant causes Ehlers–Danlos syndrome with prominent vascular features in humans and mice

A Novel Mutation in COL2A1 Leading to Spondyloepiphyseal Dysplasia Congenita in a Three-Generation Family